About Arkion®
History
Arkion® Life Sciences LLC of New Castle, Delaware, was formed in July 2001 to purchase the Life Sciences Group of DCV, Inc. and advance their development work in biotechnology and life sciences. With the acquisition, Arkion® acquired all of DCV's intellectual property, including over 400 patents and patent applications and retained all key employees. The number of patents and patent applications has since grown to over 550.
DCV, Inc. was formed in 1987 as a group of joint ventures between DuPont and ConAgra, when both companies shared the vision of bringing their technological capabilities together and diversity into the Life Sciences area. In August of 1997, the DCV management group and Windward Capital bought the joint ventures from DuPont and ConAgra.
Today Arkion® is focused on establishing several business initiatives based on its technology platforms. These include:
Biotechnology
Bio-Technical Resources (BTR), a division of Arkion® Life Sciences LLC, is a research and development organization based in Manitowoc, Wisconsin, USA. For more than four decades, BTR has offered biotechnology services helping clients transform ideas into reality. Serving the pharmaceutical, biotechnology, chemical, food and feed industries, BTR's customers include global leaders, as well as small companies and startups. BTR's technical expertise, technology transfer skills, and network of customer relationships have led to many successful alliances. BTR tailors its services to each client's specific needs, effectively becoming part of the client's research team. BTR's commitment to this customer service philosophy, combined with technical expertise, make BTR the partner of choice for biotechnology development. For more info, visit www.biotechresources.com
Hyper Immune Egg
Chickens produce in their eggs the highest level of immune products found anywhere in nature. Normally hens transfer immunities to chicks through antibodies and immuno-regulatory factors contained in their eggs. These antibodies are the result of the hens' exposure to antigens. Although, the total amount of antibodies in the egg is relatively constant, it is possible to change the profile by vaccinating against selected antigens; e.g., bacteria, viruses, proteins, etc. This natural process increases the level of target antibodies and immunoregulatory factors already present in the egg. When spray-dried, the egg product (EgCel®) can be used directly or blended with other products to provide passive immunity and immune support when consumed by humans or animals.
The result is a line of human dietary supplements, animal supplements, and pharmaceutical products containing natural immune materials that provide relief without the side effects characteristic of synthetic drugs. Controlled studies in humans and animals have confirmed that the oral administration of such antibodies and immunoregulatory factors dramatically improves performance and general health without side effects.
Significantly, most of the production steps for EgCel® products, while under our tight control are contracted. This results in little fixed Arkion® capital necessary to expand production. The unique advantages of this patented technology are: (i) oral administration, and (ii) natural derivation. The number of potential applications for this technology is only limited by one's imagination. For more information on the hyperimmune egg, visit www.hyperimmuneegg.org
The first major natural animal health product using this technology was Protimax®*, a supplement for cattle and swine that provides greater nutritional performance, improved health and better production economics.
Human dietary supplements based on the Hyper Immune Egg are sold exclusively through Legacy for Life LLC. Arkion® owns 20% of Legacy For Life and is the exclusive supplier of the egg product. For more info on Legacy For Life, visit www.legacyforlife.com
Bioactive Materials
Arkion® recently received FDA approval on N-Sure®, a natural mold toxin inhibitor for animal feed (Arkion® has spent over $10 million on the approval process). The product has the potential to improve earnings in the U.S. poultry industry by over $300 million per year.
*Protimax is a Registered
trademark of Trouw Nutrition, for spray-dried egg powder used in animal feed.